Variability of treatment for gouty arthritis between rheumatologists and primary care physicians

Journal of Clinical Rheumatology

Volumn 3, Issue 1, 1997, Pages 24-27

  Medellin, Michelle V ^a,b   Erickson, Alan R ^a   Enzenauer, Raymond J ^a  

^a FITZSIMONS ARMY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Allopurinol; Gouty arthritis; Joint aspiration; Uric acid; Uricosurics

Indexed keywords

ALLOPURINOL; COLCHICINE; PROBENECID; SULFINPYRAZONE; URIC ACID; URICOSURIC AGENT;

ADULT; AGED; ARTICLE; ASPIRATION; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RHEUMATOLOGY;

EID: 0031038356     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199702000-00005     Document Type: Article

References (18)

1. Fam AG. Should patients with interval gout be treated with urate lowering drugs? J Rheum 1995;22:1621-3.
2. Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome, unnecessary morbidity and mortality. Arthritis Rheum 1986;29:82-7.
3. Bellamy N, Gilbert JR, Brooks PM, Emerson BT, Campbell J. A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario. J Rheumatol 1988;15:1841-7.
4. Wolfe F, Cathey MA. The misdiagnosis of gout and hyperuricemia. J Rheumatol 1991;18: 1232-4.
5. Kelley WN, Schumacher HR.. In: Kelley WN, Harris E, Ruddy S, Sledge CB, editors. Gout. Textbook of rheumatology. 4th edition. Philadelphia: WB Saunders, 1993;1291-1336.
6. Bomalaski JS, Schumacher HR. Podagra is more than gout. Bull Rheum Dis 1984;34:1-7.
7. Kelley WN, Fox IH, Palella TD.. In: Kelley WN, Harris E, Ruddy S, Sledge CB, editors. Gout and related disorders of purine metabolism. Textbook of rheumatology, 3rd edition, Philadelphia: WB Saunders, 1989;1395-1448.
8. Wallace SL, Singer JZ. Therapy of gout. Rheum Dis Clin North Am 1988;14:441-57.
9. Gutman AB, Yu TF. Benemid (p-(di-n-propylsulfamylbenzoic acid) as uricosuric agent in chronic gouty arthritis. Trans Assoc Am Physicians 1951;64:279-88.
10. Kelley WN, Fox IH. In Kelley WN, Harris E, Ruddy S, Sledge CB, editors. Antihyperuricemic drugs. Textbook of rheumatology, 3rd edition. Philadelphia: WB Saunders, 1989;889-904.
11. Zell SC, Carmichael JM. Evaluation of allopurinol use in patients with gout. Am J Hosp Pharm 1989;46:1813-16.
12. Bull PW, Scott JT. Intermittent control of hyperuricernia in the treatment of gout. J Rheumatol 1989;16:1246-8.
13. Rosenthal AK, Ryan LM. Treatment of refractory crystal associated arthritis. Rheum Dis Clin North Am 1995;21:151-61.
14. McCarthy GM, Barthelemy CR, Veum JA, Wortmann RL. Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout. Arthritis Rheum 1991;34: 1489-94.
15. Paulus HE, Schlosstein LH, Godfrey RG, Klinenberg JR, Bluestone R. Prophylactic colchicine therapy of intercritical gout. Arthritis Rheum 1974;17:609-14.
16. Cohen A. Gout. Am J Med Sci 1936;192:448-93.
17. Ferraz MB. An evidenced based appraisal of the management of nontophaceous interval gout. J Rheumatol 1995;22:1618-20.
18. Ferraz MB, O'Brien B. A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis. J Rheumatol 1995;22:908-14.